INOGEN INC (INGN)

US45780L1044 - Common Stock

9.62  +0.43 (+4.68%)

After market: 9.62 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
358M
16.05%
377.2M
5.36%
315.66M
-16.31%
336.21M
6.51%
351.5M
4.55%
371.25M
5.62%
EBITDA
YoY % growth
30.83M
442.78%
-9.49M
-130.78%
-45.679M
-381.34%
-14.586M
68.07%
-7.072M
51.52%
-9.656M
-36.54%
EBIT
YoY % growth
9.2M
171.32%
-33M
-458.70%
-63.831M
-93.43%
-47.379M
25.77%
-35.87M
24.29%
-30.447M
15.12%
Operating Margin
2.57%-8.75%-20.22%-14.09%-10.20%-8.20%
EPS
YoY % growth
-0.29
-11.54%
-1.39
-379.31%
-2.99
-115.11%
-1.75
41.41%
-1.53
12.66%
-1.45
5.11%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.60
47.66%
-0.51
17.74%
-0.31
-27.50%
-0.29
-14.24%
-0.46
22.22%
-0.57
-11.00%
-0.28
7.33%
-0.28
2.50%
-0.48
-2.42%
Revenue
Q2Q % growth
76.408M
0.67%
79.642M
2.07%
91.922M
3.56%
93.106M
4.81%
86.751M
13.54%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-5.474M
49.46%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-12.818M
55.77%
N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.25
54.55%
-0.500.2550.49%
Q2 2024
Q2Q % growth
-0.24
42.86%
-0.560.3256.83%
Q1 2024
Q2Q % growth
-0.62
29.55%
-0.770.1519.81%
Q4 2023
Q2Q % growth
-1.14
-470.00%
-0.64-0.50-78.82%
Q3 2023
Q2Q % growth
-0.55
-30.95%
-0.50-0.05-9.49%
Q2 2023
Q2Q % growth
-0.42
-180.00%
-0.610.1930.66%
Q1 2023
Q2Q % growth
-0.88
-41.94%
-0.80-0.08-10.61%
Q4 2022
Q2Q % growth
-0.20
80.20%
-0.590.3965.90%
Q3 2022
Q2Q % growth
-0.42
-179.25%
-0.430.011.77%
Q2 2022
Q2Q % growth
-0.15
-168.18%
-0.380.2360.25%
Q1 2022
Q2Q % growth
-0.62
-1,966.67%
-0.52-0.10-19.42%
Q4 2021
Q2Q % growth
-1.01
-339.13%
-0.74-0.27-35.87%
Q3 2021
Q2Q % growth
0.53
762.50%
-0.270.80299.85%
Q2 2021
Q2Q % growth
0.22
83.33%
-0.110.33296.08%
Q1 2021
Q2Q % growth
-0.03
57.14%
-0.270.2489.04%
Q4 2020
Q2Q % growth
-0.23
-283.33%
-0.270.0413.83%
Q3 2020
Q2Q % growth
-0.08
-125.81%
-0.02-0.06-282.59%
Q2 2020
Q2Q % growth
0.12
-73.33%
-0.080.20253.45%
Q1 2020
Q2Q % growth
-0.07
-129.17%
-0.110.0438.08%
Q4 2019
Q2Q % growth
-0.06 0.11-0.17-156.93%
Q3 2019
Q2Q % growth
0.31 0.240.0731.57%
Q2 2019
Q2Q % growth
0.45 0.50-0.05-9.41%
Q1 2019
Q2Q % growth
0.24 0.31-0.07-22.67%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
88.834M
5.80%
85.823M3.011M3.51%
Q2 2024
Q2Q % growth
88.765M
6.13%
84.15M4.615M5.48%
Q1 2024
Q2Q % growth
78.025M
8.12%
75.136M2.889M3.85%
Q4 2023
Q2Q % growth
75.896M
-13.85%
78.526M-2.63M-3.35%
Q3 2023
Q2Q % growth
83.967M
-20.33%
84.112M-145K-0.17%
Q2 2023
Q2Q % growth
83.635M
-19.12%
94.044M-10.409M-11.07%
Q1 2023
Q2Q % growth
72.162M
-10.25%
76.171M-4.009M-5.26%
Q4 2022
Q2Q % growth
88.1M
15.31%
91.34M-3.24M-3.55%
Q3 2022
Q2Q % growth
105.4M
13.21%
99.679M5.721M5.74%
Q2 2022
Q2Q % growth
103.4M
1.77%
102.66M740K0.72%
Q1 2022
Q2Q % growth
80.4M
-7.48%
78.082M2.318M2.97%
Q4 2021
Q2Q % growth
76.4M
3.24%
77.5M-1.1M-1.42%
Q3 2021
Q2Q % growth
93.1M
25.30%
88.415M4.685M5.30%
Q2 2021
Q2Q % growth
101.6M
41.70%
90.53M11.07M12.23%
Q1 2021
Q2Q % growth
86.9M
-1.81%
80.971M5.929M7.32%
Q4 2020
Q2Q % growth
74M
-6.21%
70.452M3.548M5.04%
Q3 2020
Q2Q % growth
74.3M
-19.06%
77.585M-3.285M-4.23%
Q2 2020
Q2Q % growth
71.7M
-29.08%
81.556M-9.856M-12.08%
Q1 2020
Q2Q % growth
88.5M
-1.88%
83.64M4.86M5.81%
Q4 2019
Q2Q % growth
78.9M 88.145M-9.245M-10.49%
Q3 2019
Q2Q % growth
91.8M 93.485M-1.685M-1.80%
Q2 2019
Q2Q % growth
101.1M 109.01M-7.91M-7.26%
Q1 2019
Q2Q % growth
90.2M 91.387M-1.187M-1.30%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 2.58% 0% 10.78%
Revenue0% -6.76% 0% 0.71%